Takanori Kanazawa

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Novartis Ag, Irm LLC, Other. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takanori Kanazawa. Retrieved from https://idiyas.com/inventor/takanori-kanazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 1)

Average Co-Inventor Count = 10.6

ph-index = 5

Forward Citations = 139(Granted Patents)

Location History:

Tsukuba, JP (2006 - 2012)
Ibaraki, JP (2011 - 2012)
Tokyo, JP (2012)

Company Filing History:

1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2012

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8263590 - Pyrimidine derivatives (2012-09-11),

2. 8178559 - Organic compounds (2012-05-15),

3. 8163773 - Organic compounds (2012-04-24),

4. 8129411 - Organic compounds (2012-03-06),

5. 8084450 - Organic compounds (2011-12-27),

6. 8034810 - Arylsulfonamido-substituted hydroxamic acid derivatives (2011-10-11),

7. 7964592 - 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-06-21),

8. 7893074 - 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders (2011-02-22),

9. 7138432 - Arylsulfonamido-substituted hydroxamic acid derivatives (2006-11-21),

Title: Takanori Kanazawa: Innovator in Pharmaceutical Chemistry

Introduction

Takanori Kanazawa is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of nine patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Kanazawa has developed pyrimidine derivatives, which are novel compounds with potential uses in pharmaceuticals. These derivatives are characterized by their unique formula and processes for production. Additionally, he has worked on 3,4-substituted piperidine compounds, which are designed for the diagnostic and therapeutic treatment of diseases that depend on the activity of renin. His patents detail methods for the manufacture of these compounds, as well as pharmaceutical formulations that incorporate them.

Career Highlights

Throughout his career, Takanori Kanazawa has worked with notable companies such as Novartis AG and Irm LLC. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Kanazawa has collaborated with esteemed colleagues, including Keiichi Masuya and Werner Breitenstein. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Takanori Kanazawa's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.